Chang CS - Search Results

1

Development of Novel Rhodacyanine-Based Heat Shock Protein 70 Inhibitors.

Chang CS, Kumar V, Lee DY, Chen Y, Wu YC, Gao JY, Chu PC. Chang CS, et al. Curr Med Chem. 2021;28(26):5431-5446. doi: 10.2174/0929867328666210203204254. Curr Med Chem. 2021. PMID: 33538660

2

Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents.

Chen CY, Liu NY, Lin HC, Lee CY, Hung CC, Chang CS. Chen CY, et al. Among authors: chang cs. Eur J Med Chem. 2016 Aug 8;118:219-29. doi: 10.1016/j.ejmech.2016.03.070. Epub 2016 Mar 30. Eur J Med Chem. 2016. PMID: 27131064

3

Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors.

Chen CY, Lin CM, Lin HC, Huang CF, Lee CY, Si Tou TC, Hung CC, Chang CS. Chen CY, et al. Among authors: chang cs. Eur J Med Chem. 2017 Jan 5;125:1023-1035. doi: 10.1016/j.ejmech.2016.08.044. Epub 2016 Aug 22. Eur J Med Chem. 2017. PMID: 27810590

4

Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors.

Hsieh IS, Gopula B, Chou CC, Wu HY, Chang GD, Wu WJ, Chang CS, Chu PC, Chen CS. Hsieh IS, et al. Among authors: chang cs, chang gd. J Med Chem. 2019 Sep 26;62(18):8497-8510. doi: 10.1021/acs.jmedchem.9b00763. Epub 2019 Sep 16. J Med Chem. 2019. PMID: 31465224

5

Targeting YAP Degradation by a Novel 1,2,4-Oxadiazole Derivative via Restoration of the Function of the Hippo Pathway.

Dokla EME, Fang CS, Chu PC, Chang CS, Abouzid KAM, Chen CS. Dokla EME, et al. Among authors: chang cs. ACS Med Chem Lett. 2020 Mar 5;11(4):426-432. doi: 10.1021/acsmedchemlett.9b00501. eCollection 2020 Apr 9. ACS Med Chem Lett. 2020. PMID: 32292545 Free PMC article.

6

Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.

Hung CC, Chen CY, Wu YC, Huang CF, Huang YC, Chen YC, Chang CS. Hung CC, et al. Among authors: chang cs. Eur J Med Chem. 2020 Sep 1;201:112422. doi: 10.1016/j.ejmech.2020.112422. Epub 2020 Jun 6. Eur J Med Chem. 2020. PMID: 32569926

7

Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy.

Chu PC, Wu YC, Chen CY, Hung YS, Chang CS. Chu PC, et al. Among authors: chang cs. Future Med Chem. 2021 Jun;13(12):1057-1072. doi: 10.4155/fmc-2020-0307. Epub 2021 Apr 26. Future Med Chem. 2021. PMID: 33896195

8

Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells.

Gao JY, Chang CS, Lien JC, Chen TW, Hu JL, Weng JR. Gao JY, et al. Among authors: chang cs. Biomedicines. 2021 Oct 24;9(11):1527. doi: 10.3390/biomedicines9111527. Biomedicines. 2021. PMID: 34829756 Free PMC article.

9

Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2.

Chen Y, Yang WH, Chen HF, Huang LM, Gao JY, Lin CW, Wang YC, Yang CS, Liu YL, Hou MH, Tsai CL, Chou YZ, Huang BY, Hung CF, Hung YL, Wang WJ, Su WC, Kumar V, Wu YC, Chao SW, Chang CS, Chen JS, Chiang YP, Cho DY, Jeng LB, Tsai CH, Hung MC. Chen Y, et al. Among authors: chang cs. J Biol Chem. 2022 Mar;298(3):101658. doi: 10.1016/j.jbc.2022.101658. Epub 2022 Jan 29. J Biol Chem. 2022. PMID: 35101449 Free PMC article.

10

Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors.

Wu YC, Lu MT, Lin TH, Chu PC, Chang CS. Wu YC, et al. Among authors: chang cs. Bioorg Chem. 2022 Apr;121:105681. doi: 10.1016/j.bioorg.2022.105681. Epub 2022 Feb 12. Bioorg Chem. 2022. PMID: 35176558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,183 results

Search Page